Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05905796 · ClinicalTrials.gov registry record · NA
The Brain Health Study: A Pragmatic, Patient-Centered Trial
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,271
- Enrollment target
NCT05905796: Completed NA study, sponsored by University of California, San Francisco.
NCT05905796 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,271 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05905796, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,271 participants
- Enrollment target
Study Summary
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Primary Outcome
Rate of new dementia diagnosis identified from the electronic health record (EHR) using prespecified set of ICD-10 codes
Interventions
- OTHER Brain Health Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,271 participants |
| Start Date | 2022-12-07 |
| Est. Completion | 2026-01-26 |
| Phase | NA |
What the finished NCT05905796 record still lists
NCT05905796 is an interventional study that assigns participants to a tested intervention. Its 1,271 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Brain Health Assessment is the first listed.
NCT05905796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05905796 about?
NCT05905796 is a clinical study titled "The Brain Health Study: A Pragmatic, Patient-Centered Trial". The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
What is the current status of trial NCT05905796?
This trial is currently completed. It is a NA study. The enrollment target is 1,271 participants. The study started on 2022-12-07. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT05905796?
The interventions under investigation include: Brain Health Assessment (OTHER).
Who is sponsoring clinical trial NCT05905796?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05905796's enrollment target sits among peer trials
1,271 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI